Generic Formulations of Commonly-used Oral Drugs in Saudi Arabia:Interchangeability & Post-marketing Quality
Status:
Completed
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
Generic formulations of prescription drugs can, through their relatively lower cost, improve
healthcare as long as they maintain their registration-quality and public trust. On the other
hand, the market availability of several generic formulations raises a concern regarding
their interchangeability, despite being proven to be individually therapeutically
interchangeable with their corresponding innovator formulation.
The investigators propose to assess the quality and therapeutic interchangeability of generic
formulations in the drug market of Saudi Arabia, using fifteen, commonly-used, oral, solid,
immediate-release, and non-combinational drugs.
Phase:
N/A
Details
Lead Sponsor:
King Faisal Specialist Hospital & Research Center
Collaborator:
Saudi National Comprehensive Plan for Science & Technology